Indications & Dose:
Treatment of acute migraine with or without aura
DOSE
Adult
2.5 mg as soon as possible after onset repeated after 2 hours if migrain persist or recurs (increase to 5mg for subsquent attacks in patients not achieving satisfactory relief with 2.5mg dose); max.15mg in 24 hours
Children
Not recommended
Contraindications:
Ischemic heart disease, coroner artery vasospasm, significant underlying cardiovascular disease; uncontrolled hypertension; use within 24 hr of another 5 HT, agonist, or an ergotamine containing or ergot type medication (e.g. dihydroergotamine or methysergide); hemiplegic or basilar migraine; within 2 weeks MAO inhibitor therapy; symptomatic Wolff Parkinson White syndrome
Side Effects:
CNS: Agitation, anxiety, depression, dizziness, emotional lability, insomnia, somnolence, vertigo
CV: Bradycardia, chest pain, dysrhythmia; edema, extrasystoles, hypertension, palpitations; postural hypotension. pressure car heaviness; syncope tightness
EENT: Dry eyes, ear pain, eye pain, tinnitus
GI: Dry mouth, dyspepsia, dysphagia, nausea
GU: Hematuria, polyuria, urinary frequency, urinary urgency
MS: Myalgia, myasthenia RESP: Bronchospasm, hiccup, laryngitis, yawning
SKIN: Pruritus, rash, sweating, urticaria
MISC: Asthenia; hyperesthesia, neck, throat, jaw pain, paresthesia, pressure or tightness, warm or cold sensations
Cautions:
Precautions:
Hypertension, hypercholesterolemia, smokers, obesity, diabetes, strong family history of early CAD, peripheral vascular disease, irepaired hepatic function (initiate therapy with low dose)
Interaction:
acetaminophen: Delayed peak effect of acetaminophen (by 1 hour)
cimetidine: Prolonged zolmitriptan half-life ergot alkaloids: Prolonged vasoconstriction effects fluoxetine, fluvoxamine, paroxetine, sertraline:
Hyperreflexia, lack of coordination, and weakness
MAO inhibitors: Increased zolmitriptan effects naratriptan, rizatriptan, sumatriptan:
Prolonged zolmitriptan effects
oral contraceptives, propranolol: Increased blood zolmitriptan level
serotonin and norepinephrine reuptake inhibitors: Increased risk of developing serotonin syndrome
Warnings:
Monitor patient for signs and symptoms of vasoconstriction, which may lead to vascular and colonic ischemia with abdominal pain and bloody diarrhea, especially if patient has peripheral vascular disease (including Raynaud’s phenomenon) or ischemic bowel disease.
• Monitor elderly patients and those with hepatic impairment for increased blood pressure, and notify prescriber immediately if it occurs.
• Monitor patient closely for signs and symptoms of angina. If patient develops chest pain, notify prescriber.
WARNING
Monitor patient closely for signs and symptoms of serotonin syndrome, which may include agitation, hallucina-tions, coma, tachycardia, labile blood pressure, hyperthermia, hyperreflexia, incoordination, nausea, vomiting, and diarrhea. Notify prescriber immediately because serotonin syndrome may be lifethreatening. Be prepared to provide supportive care and discontinue zolmitriptan.
PATIENT TEACHING
• Urge patient to consult prescriber before treating more than three headaches in 30 days.
• Advise patient not to remove disintegrat-ing tablet from blister pack until just before taking the tablet. Instruct her to peel open pack, let tablet dissolve on her tongue, and then swallow.
• Urge patient to notify prescriber about unusual or severe adverse reactions
. • Caution patient using nasal spray to avoid spraying drug into her eyes.
Adverse Effects:
Lactations:
Excretion into breast milk unknown, use caution in nursing mothers
Special Precautions:
Counselling:
Side Effects Or Adverse Reactions:
CNS: Asthenia, dizziness, hyperesthesia, paresthesia, somnolence, vertigo
CV: Angina, coronary artery vasospasm, hypertension, MI, palpitations, transient myocardial ischemia, ventricular fibrillation or tachycardia
EENT: Dry mouth, vision disturbance
GI: Abdominal pain, bloody diarrhea, dysphagia, GI or splenic infarction, indiges-tion, ischemic colitis, nausea, vomiting
MS: Myalgia; myasthenia; pain, pressure, or tightness in jaw, neck, or throat
SKIN: Diaphoresis, flushing
Other: Anaphylaxis, anaphylactoid reaction, angioedema
Patient And Carer Advice:
© Pakistan Drug Directory. All Rights Reserved.
Designed By: Pakistan Drug Directory Team